Association Between Cost-Sharing and Buprenorphine Prescription Abandonment.

Kao-Ping ChuaRena M ContiPooja LagisettyAmy S B BohnertUsha NuliyaluThuy D Nguyen

Published in: Journal of general internal medicine (2024)

Among commercially insured and Medicare patients, buprenorphine prescription abandonment is rare and only minimally associated with cost-sharing. Findings suggest elimination of buprenorphine cost-sharing should only be one component of a larger, multi-faceted campaign to increase buprenorphine dispensing.

Keyphrases

health information
social media
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
patient reported outcomes
health insurance